JP2018506534A5 - - Google Patents

Download PDF

Info

Publication number
JP2018506534A5
JP2018506534A5 JP2017541934A JP2017541934A JP2018506534A5 JP 2018506534 A5 JP2018506534 A5 JP 2018506534A5 JP 2017541934 A JP2017541934 A JP 2017541934A JP 2017541934 A JP2017541934 A JP 2017541934A JP 2018506534 A5 JP2018506534 A5 JP 2018506534A5
Authority
JP
Japan
Prior art keywords
ghr
stat5
socs
halogen
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017541934A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018506534A (ja
JP6930916B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/017717 external-priority patent/WO2016130901A2/en
Publication of JP2018506534A publication Critical patent/JP2018506534A/ja
Publication of JP2018506534A5 publication Critical patent/JP2018506534A5/ja
Application granted granted Critical
Publication of JP6930916B2 publication Critical patent/JP6930916B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017541934A 2015-02-12 2016-02-12 疾患予防および治療における成長ホルモン受容体の遮断剤 Active JP6930916B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562115356P 2015-02-12 2015-02-12
US62/115,356 2015-02-12
PCT/US2016/017717 WO2016130901A2 (en) 2015-02-12 2016-02-12 Blockers of the growth hormone receptor in disease prevention and treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021018032A Division JP2021075553A (ja) 2015-02-12 2021-02-08 疾患予防および治療における成長ホルモン受容体の遮断剤

Publications (3)

Publication Number Publication Date
JP2018506534A JP2018506534A (ja) 2018-03-08
JP2018506534A5 true JP2018506534A5 (enExample) 2019-03-28
JP6930916B2 JP6930916B2 (ja) 2021-09-01

Family

ID=56615057

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017541934A Active JP6930916B2 (ja) 2015-02-12 2016-02-12 疾患予防および治療における成長ホルモン受容体の遮断剤
JP2021018032A Pending JP2021075553A (ja) 2015-02-12 2021-02-08 疾患予防および治療における成長ホルモン受容体の遮断剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021018032A Pending JP2021075553A (ja) 2015-02-12 2021-02-08 疾患予防および治療における成長ホルモン受容体の遮断剤

Country Status (14)

Country Link
US (2) US10246446B2 (enExample)
EP (1) EP3256465B1 (enExample)
JP (2) JP6930916B2 (enExample)
KR (1) KR20180016333A (enExample)
CN (1) CN107438605B (enExample)
AU (1) AU2016219173B2 (enExample)
BR (1) BR112017017182A2 (enExample)
CA (1) CA2976219C (enExample)
ES (1) ES2871551T3 (enExample)
IL (1) IL253943A0 (enExample)
MX (1) MX383010B (enExample)
NZ (1) NZ734252A (enExample)
RU (1) RU2726254C2 (enExample)
WO (1) WO2016130901A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11284640B2 (en) 2017-02-14 2022-03-29 University Of Southern California Fasting mimicking diet
CN112153974A (zh) 2018-03-15 2020-12-29 南加利福尼亚大学 禁食模仿膳食(fmd)而非仅饮水禁食促进炎症和ibd病理学的逆转

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701010D0 (sv) * 1997-03-19 1997-03-19 Pharmacia & Upjohn Ab Antibody
JPWO2002096892A1 (ja) 2001-05-31 2004-09-09 小野薬品工業株式会社 オキサジアゾール誘導体化合物およびその化合物を有効成分とする薬剤
WO2006001770A1 (en) * 2004-06-28 2006-01-05 Biovitrum Ab Method for identifying modulators of cytokine class i receptor
RU2415134C9 (ru) * 2005-08-15 2011-05-27 Этерна Центарис ГмбХ Способ лечения или профилактики физиологических и/или патофизиологических состояний, опосредуемых рецепторами, стимулирующими секрецию гормона роста, триазолы и фармацевтическая композиция на их основе
US8519137B2 (en) 2007-10-11 2013-08-27 Vertex Pharmaceuticals Incorporated Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
AU2008352540B2 (en) * 2008-03-14 2012-06-28 Biocon Limited A monoclonal antibody and a method thereof
JP5731501B2 (ja) * 2009-07-28 2015-06-10 コーニンクレッカ フィリップス エヌ ヴェ ロック構造を有するハウジング
RU2014123030A (ru) * 2011-12-22 2016-02-20 Ринат Ньюросайенс Корп. Антагонистические антитела против человеческого рецептора гормона роста и способы их применения
WO2013123511A1 (en) * 2012-02-16 2013-08-22 New York University Control of hypoxia-inducible gene expression with oligooxopiperazine nonpeptidic helix mimetics
WO2013192165A2 (en) 2012-06-20 2013-12-27 University Of Kansas Compounds and methods for activating the apoptotic arm of the unfolded protein response
KR20150124962A (ko) 2013-02-12 2015-11-06 유니버시티 오브 써던 캘리포니아 화학 독성 및 연령 관련 질병으로부터 보호하기 위한 방법 및 규정식

Similar Documents

Publication Publication Date Title
JP2016505637A5 (enExample)
JP2018535967A5 (enExample)
JP2016528301A5 (enExample)
JP2015524472A5 (enExample)
JP2016503797A5 (enExample)
JP2017528503A5 (enExample)
JP2019515908A5 (enExample)
RU2017114346A (ru) АНТАГОНИСТЫ ИНТЕГРИНА ανβ6
JP2016508134A5 (enExample)
JP2017504611A5 (enExample)
JP2013518107A5 (enExample)
JP2004531516A5 (enExample)
JP2020507589A5 (enExample)
JP2012255002A5 (enExample)
JP2020512337A5 (enExample)
JP2012513416A5 (enExample)
JP2016515628A5 (enExample)
RU2015126015A (ru) Новые улавливатели в лечении макулодистрофии
JP2019520344A5 (enExample)
JP2019535723A5 (enExample)
JP2010521516A5 (enExample)
JP2011530607A5 (enExample)
JP2016522254A5 (enExample)
JP2015516419A5 (enExample)
JP2016513124A5 (enExample)